China NMPA Drug Inspection - Zhangye Hengli Traditional Chinese Medicine Processing Co., Ltd. - Fried Bran-Fried Fructus Aurantii Immaturus
China NMPA drug inspection for Zhangye Hengli Traditional Chinese Medicine Processing Co., Ltd. published May 04, 2018. Drug: Fried Bran-Fried Fructus Aurantii Immaturus. The Gansu Provincial Food and Drug Administration issued a drug quality announcement on May 4, 2018, detailing non-compl
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Zhangye Hengli Traditional Chinese Medicine Processing Co., Ltd. published May 04, 2018. Drug: Fried Bran-Fried Fructus Aurantii Immaturus. The Gansu Provincial Food and Drug Administration issued a drug quality announcement on May 4, 2018, detailing non-compl
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox